
FDA Awards Orphan Drug Designation for Brain Cancer Drug Development by Helix 51 Company
Published on December 25, 2024
for glioblastoma using oncolytic Zika virus.” Aimed at minimizing funding gaps, fast-track grants are awarded to projects that have a high
Other news
